IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BUGATTI, Antonella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.599
EU - Europa 3.952
AS - Asia 2.145
SA - Sud America 396
AF - Africa 45
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 7
Totale 11.154
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.543
PL - Polonia 2.452
CN - Cina 779
SG - Singapore 654
UA - Ucraina 402
BR - Brasile 340
DE - Germania 281
HK - Hong Kong 250
IT - Italia 196
VN - Vietnam 186
FI - Finlandia 164
GB - Regno Unito 124
TR - Turchia 84
RU - Federazione Russa 80
IE - Irlanda 74
IN - India 49
FR - Francia 46
ID - Indonesia 34
CA - Canada 32
SE - Svezia 28
BD - Bangladesh 23
CZ - Repubblica Ceca 19
ZA - Sudafrica 19
IQ - Iraq 17
MX - Messico 17
AR - Argentina 16
ES - Italia 16
AT - Austria 15
BE - Belgio 11
JP - Giappone 11
AU - Australia 10
EC - Ecuador 10
NL - Olanda 10
VE - Venezuela 8
CL - Cile 7
PE - Perù 7
SA - Arabia Saudita 7
EG - Egitto 6
EU - Europa 6
JO - Giordania 6
PK - Pakistan 6
PT - Portogallo 6
UZ - Uzbekistan 6
DZ - Algeria 5
KE - Kenya 5
LK - Sri Lanka 5
MA - Marocco 5
AZ - Azerbaigian 4
IR - Iran 4
LT - Lituania 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
DK - Danimarca 3
KR - Corea 3
PA - Panama 3
AL - Albania 2
CO - Colombia 2
HR - Croazia 2
JM - Giamaica 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MD - Moldavia 2
NP - Nepal 2
PS - Palestinian Territory 2
PY - Paraguay 2
RO - Romania 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
HU - Ungheria 1
IS - Islanda 1
KW - Kuwait 1
LV - Lettonia 1
MM - Myanmar 1
NO - Norvegia 1
OM - Oman 1
SI - Slovenia 1
Totale 11.154
Salva come PNG Salva come JPEG
Città #
Warsaw 2.450
Fairfield 549
Ashburn 425
Woodbridge 325
Houston 303
Singapore 293
Jacksonville 282
Hong Kong 249
Chandler 235
Cambridge 221
Seattle 214
Beijing 199
Wilmington 195
Ann Arbor 191
Dallas 170
New York 137
Princeton 131
Los Angeles 97
Helsinki 89
Dong Ket 87
Nanjing 84
Dublin 74
Brescia 73
Munich 70
Istanbul 68
The Dalles 59
Ho Chi Minh City 41
Jinan 41
Nanchang 37
San Francisco 37
Shanghai 36
São Paulo 33
Boardman 32
Des Moines 32
Dearborn 30
San Diego 29
Changsha 28
Hebei 28
Shenyang 27
Redondo Beach 26
Buffalo 25
Phoenix 25
Jakarta 24
Chicago 22
London 20
Tianjin 20
Milan 19
Moscow 19
Jiaxing 18
Stockholm 18
Turku 18
Johannesburg 16
Parma 15
Brno 14
Brooklyn 14
Hanoi 14
Lancaster 14
Toronto 14
Zhengzhou 14
Santa Clara 13
Atlanta 12
Denver 12
Guangzhou 12
Haikou 12
Hangzhou 12
Manchester 12
Boston 11
Charlotte 11
Nuremberg 11
Tokyo 11
Rio de Janeiro 10
Verona 10
Lanzhou 9
Montreal 9
Orem 9
Brussels 8
Kilburn 8
Kunming 8
Salt Lake City 8
Belo Horizonte 7
Norwalk 7
Porto Alegre 7
Taiyuan 7
Amman 6
Augusta 6
Caxias do Sul 6
Chennai 6
Curitiba 6
Erbil 6
Fuzhou 6
Logan 6
Mexico City 6
Ningbo 6
Tashkent 6
Baghdad 5
Colombo 5
Council Bluffs 5
Fortaleza 5
Guarulhos 5
Gunzenhausen 5
Totale 8.402
Salva come PNG Salva come JPEG
Nome #
Bridging the past and the future of virology: Surface plasmon resonance as a powerful tool to investigate virus/host interactions. 338
Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use 293
Biological role of immunoglobulin Free light chains interactomes 289
Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists. 284
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. 281
Δ5-Cholenoyl-amino acids as selective and orally available antagonists of the Epheephrin system 279
BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: prototype for the development of multitarget inhibitors of extracellular Tat 270
Activation of Hsp90 Enzymatic Activity and Conformational Dynamics through Rationally Designed Allosteric Ligands 270
Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery 264
Speeding Up the Identification of Cystic Fibrosis Transmembrane Conductance Regulator-Targeted Drugs: An Approach Based on Bioinformatics Strategies and Surface Plasmon Resonance 261
Inhibition of Non Canonical HIV-1 Tat Secretion Through the Cellular Na+,K+-ATPase Blocks HIV-1 Infection 252
Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists. 248
Membrane association of peroxiredoxin-2 in red cells is mediated by n-terminal cytoplasmic domain of band 3 245
Integrating computational and chemical biology tools in the discovery of antiangiogenic small molecule ligands of FGF2 derived from endogenous inhibitors 244
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived antiangiogenic pentapeptide. 241
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected mice 232
A complex of α(6) integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. 225
Functionalization of gold surfaces with copoly(DMA-NAS-MAPS) by dip coating: Surface characterization and hybridization tests 224
Pradamicin A: a new therapeutic concept for tretment of virus infections with a glycosilated envelope such as human immunodeficiency virus 212
The agmatine-containing poly(Amidoamine) polymer AGMA1 binds cell surface heparan sulfates and prevents attachment of mucosal human papillomaviruses 210
Chemoselective surface immbolization of proteins through a cleavable peptide 196
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 193
Molecular Interaction Studies of HIV-1 Matrix Protein p17 and Heparin: IDENTIFICATION OF THE HEPARIN-BINDING MOTIF OF p17 AS A TARGET FOR THE DEVELOPMENT OF MULTITARGET ANTAGONISTS 191
A CXCR1 haplotype hampers HIV-1 matrix protein p17 biological activity 174
Merging colloidal nanoplasmonics and surface plasmon resonance spectroscopy for enhanced profiling of multiple myeloma-derived exosomes 166
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an anti-angiogenic multi-target fibroblast growth factor-2 antagonist. 165
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 154
Heparin and heparan sulfate proteoglycans promote HIV-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 153
Cellular aspartyl proteases promote the unconventional secretion of biologically active HIV-1 matrix protein p17 151
HIV-1 matrix protein p17 binds to the IL-8 receptor CXCR1 and shows IL-8-like chemokine activity on monocytes through Rho/ROCK activation 143
Mycoplasma infection may complicate the clinical course of SARS-Co-V-2 associated Kawasaki-like disease in children 142
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysis 141
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy 138
Angiostatic, tumor inflammatory and anti-tumor effects of CXCL4(47-70) and CXCL4L1(47-70) in an EGF-dependent breast cancer model. 134
A persistently replicating SARS-CoV-2 variant derived from an asymptomatic individual 133
Exploiting Surface Plasmon Resonance (SPR) Technology for the Identification of Fibroblast Growth Factor-2 (FGF2) Antagonists Endowed with Antiangiogenic Activity 132
The calcium-binding type III repeats domain of thrombospondin-2 binds to fibroblast growth factor 2 (FGF2) 132
HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2 130
alpha v beta 3 integrin-dependent activation of focal adhesion kinase mediates NF-kB activation and motogenic activity by HIV-1 Tat in endothelial cells 129
Sulfated K5 Escherichia coli polysaccharide derivatives as wide range inhibitors of genital types of human papillomavirus 119
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding Peptide. 119
Surface plasmon resonance analysis of heparin-binding angiogenic growth factors 119
The synthetic dipeptide pidotimod shows a chemokine-like activity through cxc chemokine receptor 3 (Cxcr3) 118
Plasmonic exosomes for enhanced monitoring of monoclonal gammopathies 117
Positively charged peptides can interact with each other as revealed by solid phase binding assays 114
Direct and Allosteric Inhibition of the FGF2/HSPGs/FGFR1 Ternary Complex Formation by an Antiangiogenic, Thrombospondin-1-Mimic Small Molecule. 112
Avian Reovirus P17 Suppresses Angiogenesis by Promoting DPP4 Secretion 112
Angiogenic growth factor-endothelial cell interaction: receptor binding and cell internalization techniques 108
Peptide-Derivatized SB105-A10 Dendrimer Inhibits the Infectivity of R5 and X4 HIV-1 Strains in Primary PBMCs and Cervicovaginal Histocultures 106
Identification of a dendrimeric heparan sulfate-binding peptide that inhibits infectivity of genital types of human papillomaviruses 105
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 102
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 99
EXPLOTING SURFACE PLASMON RESONANCE (SPR) TECHNOLOGY FOR THE IDENTIFICATION OF FIBROBLAST GROWTH FACTOR-2 (FGF2) ANTAGONISTS ENDOWED WITH ANTI-ANGIOGENIC ACTIVITY 97
FGF2- Antagonist activity of long pentraxin-3 97
Methotrexate inhibits SARS-CoV-2 virus replication “in vitro” 97
FGF2-Antagonist activity of long pentraxin-3 related peptides 93
Evolution toward beta common chain receptor usage links the matrix proteins of HIV-1 and its ancestors to human erythropoietin 92
B-cell clonogenic activity of HIV-1 p17 variants is driven by PAR1-mediated EGF transactivation 91
HIV-1 mutants expressing B cell clonogenic matrix protein p17 variants are increasing their prevalence worldwide 88
Sars-cov-2 infection remodels the phenotype and promotes angiogenesis of primary human lung endothelial cells 87
Role of autophagy in von willebrand factor secretion by endothelial cells and in the in vivo thrombin-antithrombin complex formation promoted by the hiv-1 matrix protein p17 84
The NLS of the HIV-1 Tat protein interacts with the fd bacteriophage and with a peptide derived from its p8 protein 79
Competition for dominance within replicating quasispecies during prolonged SARS-CoV-2 infection in an immunocompromised host 78
exploiting surface plasmon resonance technology for the identification of fibroblast growth factor 2 (FGF2) antagonists endowed with antiangiogenic activity 77
Identification of an anti-angiogenic FGF2-binding site in the n-terminal extension of the soluble pattern recognition receptor long-pentraxin PTX3 76
Human Metapneumovirus Establishes Persistent Infection in Lung Microvascular Endothelial Cells and Primes a Th2-Skewed Immune Response 74
inhibition of intra- and extra-cellular Tat function and HIV expression by pertussin toxin B-oligomer 71
development of novel small molecules mimicking thrombospondin-1 (TSP-1) antiangiogenic activity 70
Temporal viral loads in respiratory and gastrointestinal tract and serum antibody responses during SARS-CoV-2 infection in an Italian pediatric cohort 65
SARS-CoV-2 Infects Human ACE2-Negative Endothelial Cells through an αvβ3 Integrin-Mediated Endocytosis Even in the Presence of Vaccine-Elicited Neutralizing Antibodies 62
DHFR Inhibitors Display a Pleiotropic Anti-Viral Activity against SARS-CoV-2: Insights into the Mechanisms of Action 62
Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host 60
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 59
Characterization of raloxifene as a potential pharmacological agent against SARS-CoV-2 and its variants 58
heparin and heparan sulfate proteoglycans promotes hiv-1 p17 matrix protein oligomerization: computational, biochemical and biological implications 48
Paclitaxel binds and activates C5aR1: A new potential therapeutic target for the prevention of chemotherapy-induced peripheral neuropathy and hypersensitivity reactions 33
Totale 11.307
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.933
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.933
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.033 0 0 0 0 0 166 118 202 155 155 114 123
2021/2022627 37 147 15 18 16 15 32 46 33 72 59 137
2022/2023565 75 30 22 35 52 136 2 77 85 3 28 20
2023/2024699 44 10 61 39 42 116 31 27 152 28 31 118
2024/20251.384 15 9 11 226 108 119 78 61 154 136 275 192
2025/20261.787 249 354 340 474 327 43 0 0 0 0 0 0
Totale 11.307